08/08/2024 6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/21/2024 6:30 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 12:35 PM | Ironwood Pharmaceuticals (Subject) Moukheibir Catherine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024 3:46 PM | Ironwood Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 6:09 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/25/2024 3:26 PM | Ironwood Pharmaceuticals (Filer)
| Form DEF 14A | |
04/25/2024 3:28 PM | Ironwood Pharmaceuticals (Filer)
| Form DEFA14A | |
|
04/25/2024 3:31 PM | Ironwood Pharmaceuticals (Filer)
| Form ARS | |
02/16/2024 6:01 AM | Ironwood Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 6:04 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 8:01 PM | Ironwood Pharmaceuticals (Issuer) John Minardo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:50 PM | Ironwood Pharmaceuticals (Issuer) Silver Ronald (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:53 PM | Ironwood Pharmaceuticals (Issuer) Shetzline Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:35 PM | Ironwood Pharmaceuticals (Issuer) MCCOURT Thomas A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:39 PM | Emany Sravan Kumar (Reporting) Ironwood Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 7:42 PM | Davis Andrew (Reporting) Ironwood Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 2:12 PM | Ironwood Pharmaceuticals (Subject) LSV ASSET MANAGEMENT (Filed by)
| Form SC 13G/A | |
01/25/2024 8:21 AM | Ironwood Pharmaceuticals (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/22/2024 1:03 PM | BlackRock Inc. (Filed by) Ironwood Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/19/2024 3:05 PM | Emany Sravan Kumar (Reporting) Ironwood Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:05 PM | Ironwood Pharmaceuticals (Issuer) John Minardo (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:05 PM | Ironwood Pharmaceuticals (Issuer) Shetzline Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 3:05 PM | Ironwood Pharmaceuticals (Issuer) MCCOURT Thomas A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 9:16 AM | Ironwood Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
01/08/2024 5:05 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/14/2023 3:26 PM | Ironwood Pharmaceuticals (Subject) Kessler Marla L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023 6:07 AM | Ironwood Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/18/2023 4:07 PM | Emany Sravan Kumar (Reporting) Ironwood Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2023 3:30 PM | Ironwood Pharmaceuticals (Filer)
| Form 8-K/A | |